Cilj: Utvrđivanje učestalosti mikroalbuminurije (MA) kod bolesnika s koronarnom bolesti srca (KBS), arterijskom hipertenzijom (AH), hiperkolesterolemijom (HK) i metaboličkim sindromom (MS).
Metode: Analizirani su bolesnici hospitalizirani u koronarnoj jedinici i na kardiologiji Opće bolnice u Karlovcu u periodu od 1. do 9. mjeseca 2009. godine. Analizirane su četiri nerenalne bolesti: KBS, AH, HK i MS. Bilo je 176 bolesnika; 120 bolesnika nije imalo MA, a 56 bolesnika je imalo MA. Muškaraca je bilo 122 (69 %), a žena 54 (31 %). Ukupni raspon dobi bolesnika bio je od 36 do 84 godine, a prosječna dob bila je 62.8 godina.
Rezultati: Kod MS je učestalost MA statistički značajna prema KBS (45,5 vs 31,0 %; Z = 1,831; p < 0,05) i HK (45,5 vs 28,4 %; Z = 1,919; p < 0,05), ali nije značajna prema AH (45,5 vs 35,9 %; Z = 1,13; n.s.).
Zaključak: Značajno veću učestalost MA imaju bolesnici s MS, dok kod bolesnika s AH, KBS i HK nema razlike.Aim: To determine microalbuminuria (MA) in patients with coronary heart disease (CHD), arterial hypertension (AH), hypercholesterolemia (HC) and metabolic syndrome (MS).
Methods: The patients who were hospitalized in the coronary unit and at the Department of cardiology of the General hospital in Karlovac from January till September 2009 were studied. The study comprised four non-renal diseases: CHD, AH, HC and MS. There were 176 patients in total, out of which 120 patients had no MA and 56 patients had MA. The study comprised 122 male patients (69 %) and 54 female patients (31 %). The total age range of the patients was from 36 to 84 years of age. The average age was 62.8.
Results: In the case of MS the occurrence of MA was statistically significant to CHD (45,5 vs 31,0 %; Z=1,831; p<0,05) and HC (45,5 vs 28,4 %; Z=1,919; p<0,05), but was not statistically significant to AH (45,5 vs 35,9 %; Z=1,13; n.s.).
Conclusion: Patients with MS have a significantly greater frequency of MA. However, in patients with AH, CHD and HC there is no difference
